Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90908647 | 9090864 | 7 | F | 20120608 | 20160830 | 20130131 | 20160907 | EXP | PHHY2012JP104429 | NOVARTIS | 54.16 | YR | M | Y | 56.00000 | KG | 20160907 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90908647 | 9090864 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 1420 | MG | 22334 | 10 | MG | TABLET | QD | ||||
| 90908647 | 9090864 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 1420 | MG | 22334 | 10 | MG | TABLET | QD | ||||
| 90908647 | 9090864 | 3 | C | JUVELA | .ALPHA.-TOCOPHEROLRETINOL | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 90908647 | 9090864 | 4 | C | METHYCOBAL | METHYLCOBALAMIN | 1 | Oral | 1500 UG, UNK | 0 | 1500 | UG | ||||||||
| 90908647 | 9090864 | 5 | C | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, UNK | U | U | 0 | 20 | MG | ||||||
| 90908647 | 9090864 | 6 | C | THYRADIN | LEVOTHYROXINE | 1 | Oral | 150 UG, UNK | U | U | 0 | 150 | UG | ||||||
| 90908647 | 9090864 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 90908647 | 9090864 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | UNK | 0 | ||||||||||
| 90908647 | 9090864 | 9 | C | LIVACT | AMINO ACIDS | 1 | Oral | UNK | U | U | 0 | ||||||||
| 90908647 | 9090864 | 10 | C | FLIVAS | NAFTOPIDIL | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90908647 | 9090864 | 1 | Pancreatic neuroendocrine tumour |
| 90908647 | 9090864 | 5 | Pancreatic neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 90908647 | 9090864 | HO |
| 90908647 | 9090864 | OT |
| 90908647 | 9090864 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90908647 | 9090864 | Ataxia | |
| 90908647 | 9090864 | C-reactive protein increased | |
| 90908647 | 9090864 | Diabetic nephropathy | |
| 90908647 | 9090864 | Diarrhoea | |
| 90908647 | 9090864 | Glycosylated haemoglobin increased | |
| 90908647 | 9090864 | Hyperglycaemia | |
| 90908647 | 9090864 | Hypoaesthesia | |
| 90908647 | 9090864 | Hypoalbuminaemia | |
| 90908647 | 9090864 | Impaired insulin secretion | |
| 90908647 | 9090864 | Lumbar spinal stenosis | |
| 90908647 | 9090864 | Malaise | |
| 90908647 | 9090864 | Muscular weakness | |
| 90908647 | 9090864 | Oedema peripheral | |
| 90908647 | 9090864 | Pyrexia | |
| 90908647 | 9090864 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 90908647 | 9090864 | 1 | 20120119 | 20120608 | 0 | |
| 90908647 | 9090864 | 2 | 20120623 | 0 | ||
| 90908647 | 9090864 | 5 | 20111031 | 0 | ||
| 90908647 | 9090864 | 7 | 20130404 | 0 | ||
| 90908647 | 9090864 | 9 | 20130627 | 0 |